chr19-48968838-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002103.5(GYS1):c.*450G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00224 in 459,378 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0021 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 15 hom. )
Consequence
GYS1
NM_002103.5 3_prime_UTR
NM_002103.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.372
Genes affected
GYS1 (HGNC:4706): (glycogen synthase 1) The protein encoded by this gene catalyzes the addition of glucose monomers to the growing glycogen molecule through the formation of alpha-1,4-glycoside linkages. Mutations in this gene are associated with muscle glycogen storage disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-48968838-C-T is Benign according to our data. Variant chr19-48968838-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 329799.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00207 (315/152348) while in subpopulation EAS AF= 0.0435 (225/5172). AF 95% confidence interval is 0.0388. There are 7 homozygotes in gnomad4. There are 163 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GYS1 | NM_002103.5 | c.*450G>A | 3_prime_UTR_variant | 16/16 | ENST00000323798.8 | ||
GYS1 | NM_001161587.2 | c.*450G>A | 3_prime_UTR_variant | 15/15 | |||
GYS1 | NR_027763.2 | n.2679G>A | non_coding_transcript_exon_variant | 15/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GYS1 | ENST00000323798.8 | c.*450G>A | 3_prime_UTR_variant | 16/16 | 1 | NM_002103.5 | P1 | ||
GYS1 | ENST00000263276.6 | c.*450G>A | 3_prime_UTR_variant | 15/15 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00208 AC: 316AN: 152230Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
316
AN:
152230
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00414 AC: 542AN: 131056Hom.: 8 AF XY: 0.00378 AC XY: 270AN XY: 71506
GnomAD3 exomes
AF:
AC:
542
AN:
131056
Hom.:
AF XY:
AC XY:
270
AN XY:
71506
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00232 AC: 712AN: 307030Hom.: 15 Cov.: 0 AF XY: 0.00227 AC XY: 396AN XY: 174652
GnomAD4 exome
AF:
AC:
712
AN:
307030
Hom.:
Cov.:
0
AF XY:
AC XY:
396
AN XY:
174652
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00207 AC: 315AN: 152348Hom.: 7 Cov.: 32 AF XY: 0.00219 AC XY: 163AN XY: 74492
GnomAD4 genome
AF:
AC:
315
AN:
152348
Hom.:
Cov.:
32
AF XY:
AC XY:
163
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
71
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary hyperferritinemia with congenital cataracts Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Neuroferritinopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2021 | - - |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at